KPTI
Karyopharm Therapeutics Inc. · Healthcare
Director Deepika Pakianathan sold $785K of Karyopharm Therapeutics Inc.
Sold$785,027
$0.96Price
818,044Shares
−100%Stake
What KPTI did after the filing
- The stock from Fri, Jun 7 close, $14.40
- −3.6%
- S&P 500, same days
- +4.0%
Measured over 30 trading days, to the Jul 23 close.
Traded Wed, Jun 5. Filed Fri, Jun 7, 3:18 PM ET, during the session. Returns use the Jun 7 close and the Jul 23 close. Not investment advice.